CFR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cullen/Frost Bankers (CFR) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock’s technical setup is still constructive, but the current price is not an attractive entry after a strong run, and analyst sentiment is mixed with several ratings already neutral-to-negative. Since the investor is impatient and unwilling to wait for an optimal entry, the best direct call based on the full dataset is HOLD rather than buy. The stock looks fundamentally solid, but the present risk/reward is only fair, not compelling.
CFR’s trend is bullish overall: SMA_5 is above SMA_20 and SMA_20 is above SMA_200, which confirms a positive medium- to long-term trend. MACD histogram is positive at 0.703, though it is contracting, suggesting momentum is still supportive but may be cooling. RSI_6 at 72.809 is elevated and points to a stretched short-term condition even if the model labels it neutral. Price at 151.88 is below the prior close of 154.86 and sits near the pivot of 151.688, with resistance at 156.303 and support at 147.073. The short-term pattern outlook is weak over the next month (-2.76%), which reduces confidence in buying immediately at current levels.
Recent analyst commentary includes several constructive notes: Raymond James previously highlighted broad-based EPS and PPNR upside, improved NII/NIM, loan growth, and credit quality, while Stephens upgraded the stock to Overweight and cited organic expansion and stronger profitability. The broader technical trend is also favorable, and options positioning is bullish. The stock remains a relatively defensive bank name with solid fundamentals.
Analyst sentiment has recently turned more cautious overall: Raymond James downgraded CFR to Market Perform from Outperform due to valuation, Citi keeps a Sell rating, and Morgan Stanley retains Underweight despite raising its target. The shares have already risen about 22% year-to-date, limiting upside from current levels. There is no fresh news catalyst in the last week, and the short-term pattern forecast points to a weak next-month return profile. The recent price action also shows the stock slipping from 154.86 to 151.88.
No latest-quarter financial snapshot was available because the provided financial data returned an error. From the analyst notes, the most recent quarter appeared strong: EPS and PPNR beat expectations, and guidance or outlook improvements were noted for NII, NIM, loan growth, credit quality, and lower LLP expense. Based on that, the latest quarter season appears to have been positive, but the exact reported figures are not available here.
Analyst trend is mixed to cautious. Positive changes included Stephens upgrading to Overweight and earlier target increases from Raymond James and others after a strong earnings report. However, the most recent updates are more defensive: Raymond James downgraded to Market Perform citing valuation, Citi maintains Sell while lifting its target, and Morgan Stanley keeps Underweight. Wall Street’s pros see solid fundamentals, defensive quality, and organic growth, while the cons center on valuation, limited upside after the rally, and a risk/reward balance that is no longer compelling. Overall, analyst tone has shifted from bullish to neutral/cautious.
